Molecular Subtypes of Pulmonary Large-cell Neuroendocrine Carcinoma Predict Chemotherapy Treatment Outcome

, Jules L. Derks, Noemie Leblay, Erik Thunnissen, Robert Jan Van Suylen, Michael den Bakker, Harry J. M. Groen, Egbert F. Smit, Ronald Damhuis, Esther C. van den Broek, Amelie Charbrier, Matthieu Foll, James D. McKay, Lynnette Fernandez-Cuesta, Ernst-Jan M. Speel, Anne-Marie C. Dingemans

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)33-42
Number of pages10
JournalClinical Cancer Research
Volume24
Issue number1
DOIs
Publication statusPublished - 1 Jan 2018

Keywords

  • MULTICENTER-PHASE-II
  • LUNG-CANCER
  • SURGICAL SPECIMENS
  • TUMORS
  • EXPRESSION
  • REPRODUCIBILITY
  • NEOPLASMS
  • CISPLATIN
  • FEATURES
  • THERAPY

Cite this

Derks, Jules L. ; Leblay, Noemie ; Thunnissen, Erik ; Van Suylen, Robert Jan ; den Bakker, Michael ; Groen, Harry J. M. ; Smit, Egbert F. ; Damhuis, Ronald ; van den Broek, Esther C. ; Charbrier, Amelie ; Foll, Matthieu ; McKay, James D. ; Fernandez-Cuesta, Lynnette ; Speel, Ernst-Jan M. ; Dingemans, Anne-Marie C. / Molecular Subtypes of Pulmonary Large-cell Neuroendocrine Carcinoma Predict Chemotherapy Treatment Outcome. In: Clinical Cancer Research. 2018 ; Vol. 24, No. 1. pp. 33-42.
@article{5fd19f26cd514419a362ef37e3484501,
title = "Molecular Subtypes of Pulmonary Large-cell Neuroendocrine Carcinoma Predict Chemotherapy Treatment Outcome",
keywords = "MULTICENTER-PHASE-II, LUNG-CANCER, SURGICAL SPECIMENS, TUMORS, EXPRESSION, REPRODUCIBILITY, NEOPLASMS, CISPLATIN, FEATURES, THERAPY",
author = "Derks, {Jules L.} and Noemie Leblay and Erik Thunnissen and {Van Suylen}, {Robert Jan} and {den Bakker}, Michael and Groen, {Harry J. M.} and Smit, {Egbert F.} and Ronald Damhuis and {van den Broek}, {Esther C.} and Amelie Charbrier and Matthieu Foll and McKay, {James D.} and Lynnette Fernandez-Cuesta and Speel, {Ernst-Jan M.} and Dingemans, {Anne-Marie C.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1158/1078-0432.CCR-17-1921",
language = "English",
volume = "24",
pages = "33--42",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "1",

}

Derks, JL, Leblay, N, Thunnissen, E, Van Suylen, RJ, den Bakker, M, Groen, HJM, Smit, EF, Damhuis, R, van den Broek, EC, Charbrier, A, Foll, M, McKay, JD, Fernandez-Cuesta, L & Speel, E-JM & Dingemans, A-MC 2018, 'Molecular Subtypes of Pulmonary Large-cell Neuroendocrine Carcinoma Predict Chemotherapy Treatment Outcome', Clinical Cancer Research, vol. 24, no. 1, pp. 33-42. https://doi.org/10.1158/1078-0432.CCR-17-1921

Molecular Subtypes of Pulmonary Large-cell Neuroendocrine Carcinoma Predict Chemotherapy Treatment Outcome. / ; Derks, Jules L.; Leblay, Noemie; Thunnissen, Erik; Van Suylen, Robert Jan; den Bakker, Michael; Groen, Harry J. M.; Smit, Egbert F.; Damhuis, Ronald; van den Broek, Esther C.; Charbrier, Amelie; Foll, Matthieu; McKay, James D.; Fernandez-Cuesta, Lynnette; Speel, Ernst-Jan M.; Dingemans, Anne-Marie C.

In: Clinical Cancer Research, Vol. 24, No. 1, 01.01.2018, p. 33-42.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Molecular Subtypes of Pulmonary Large-cell Neuroendocrine Carcinoma Predict Chemotherapy Treatment Outcome

AU - Derks, Jules L.

AU - Leblay, Noemie

AU - Thunnissen, Erik

AU - Van Suylen, Robert Jan

AU - den Bakker, Michael

AU - Groen, Harry J. M.

AU - Smit, Egbert F.

AU - Damhuis, Ronald

AU - van den Broek, Esther C.

AU - Charbrier, Amelie

AU - Foll, Matthieu

AU - McKay, James D.

AU - Fernandez-Cuesta, Lynnette

AU - Speel, Ernst-Jan M.

AU - Dingemans, Anne-Marie C.

PY - 2018/1/1

Y1 - 2018/1/1

KW - MULTICENTER-PHASE-II

KW - LUNG-CANCER

KW - SURGICAL SPECIMENS

KW - TUMORS

KW - EXPRESSION

KW - REPRODUCIBILITY

KW - NEOPLASMS

KW - CISPLATIN

KW - FEATURES

KW - THERAPY

U2 - 10.1158/1078-0432.CCR-17-1921

DO - 10.1158/1078-0432.CCR-17-1921

M3 - Article

VL - 24

SP - 33

EP - 42

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 1

ER -